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Abstract: The aim of this study was to identify sources of cheap starting materials for the 
synthesis of new drugs against Helicobacter pylori. Solvent-extracts of selected medicinal 
plants; Combretum molle, Sclerocarya birrea, Garcinia kola, Alepidea amatymbica and a 
single Strychnos species were investigated against 30 clinical strains of H. pylori alongside 
a  reference  control  strain  (NCTC  11638)  using  standard  microbiological  techniques. 
Metronidazole  and  amoxicillin  were  included  in  these  experiments  as  positive  control 
antibiotics.  All  the  plants  demonstrated  anti-H.  pylori  activity  with  zone  diameters  of 
inhibition  between  0  and  38  mm  and  50%  minimum  inhibitory  concentration  (MIC50) 
values ranging from 0.06 to 5.0 mg/mL. MIC50 values for amoxicillin and metronidazole 
ranged  from  0.001  to  0.63  mg/mL  and  0.004  to  5.0  mg/mL  respectively.  The  acetone 
extracts  of  C.  molle  and  S.  birrea  exhibited  a  remarkable  bactericidal  activity  against  
H.  pylori  killing  more  than  50%  of  the  strains  within  18  h  at  4×  MIC  and  complete 
elimination of the organisms within 24 h. Their antimicrobial activity was comparable to 
the control antibiotics. However, the activity of the ethanol extract of G. kola was lower 
than  amoxicillin  (P  <  0.05)  as  opposed  to  metronidazole  (P  >  0.05).  These  results 
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demonstrate that S. birrea, C. molle and G. kola may represent good sources of compounds 
with anti-H. pylori activity.  
Keywords: drug discovery; Helicobacter pylori; medicinal plants; antimicrobial activity 
 
1. Introduction 
Helicobacter  pylori,  a  gram  negative  microearophilic  helical  bacillus  inhabits  the  stomach  of 
approximately half of the human population, in whom it may persist for a life time, making it one of 
the most successful  human pathogens [1]. Infection with this organism  is strongly  associated with 
chronic active gastritis, peptic ulcer and mucosa associated lymphoid tissue (MALT) lymphoma [2]. 
The organism is classified by the World Health Organization and the International agency for Research 
on Cancer as a class 1 carcinogen [3]. 
Eradication  of  the  organism  from  the  stomach  results  in  significant  remission  from  the  above 
diseases [4]. Current eradication regimens involve the use of combination therapies; a proton pump 
inhibitor  (PPI)  or  bismuth  compounds  and  two  antibiotics,  most  commonly  clarithromycin  and 
metronidazole or amoxicillin [5], with an expected success rate of 80%–90% [6]. However, H. pylori 
infection is still difficult to treat as eradication failure rate remains at 10%–40% [7,8]. 
Antimicrobial  resistance  to  current  regimens  is  increasingly  recognized  as  a  major  cause  of 
treatment  failure  [9].  With  primary  susceptibility  patterns  becoming  less  predictable,  it  is  not 
uncommon to find other stronger antibiotics, particularly from the flouroquinolone group, being part of 
the  treatment  regimen  [10],  but  H.  pylori  is  developing  resistance  to  these  drugs  too  [11].  Other 
problems,  including  undesirable  side  effects  (nausea,  vomiting,  diarrhea,  stomach  ache)  and  poor 
patient compliance are associated with significant levels of treatment failure and contraindications for 
some patients [8]. In addition, combination therapy is not readily affordable and some of the drugs are 
not available in some rural settings in the developing world. These factors and others have necessitated 
the  search  for  alternative  treatment  regimens  with  highly  selective  activity  against  the  organism, 
without the risk of resistance or other untoward effects. 
The  use  of  medicinal  plants  for  the  treatment  of  diseases  is  a  common  phenomenon  in  most  
African countries, particularly in areas where medical health facilities are not readily accessible or 
affordable [12]. Thus, plants would seem to be a logical source of new anti-H. pylori compounds.  
In fact, our previous studies have documented that some medicinal plant extracts have antibacterial 
activity against H. pylori [13–15]. 
Combretum molle, Sclerocarya birrea, Garcinia kola, Alepidea amatymbica and some Strychnos 
species  have  found  ethno  medicinal  uses  in  the  treatment  of  gastritis,  peptic  ulcer  and  other  
H. pylori-associated morbidities in South Africa and other African countries [6,16,17]. The medicinal 
properties of most of these plants have been a subject of numerous investigations [18–20]. However, 
reports on their anti-H. pylori activity are lacking. This is surprising, given that H. pylori antimicrobial 
resistance  to  current treatment  regimens  is  increasingly  recognized  as  a  major  cause  of  treatment 
failure.  This  study  was  therefore  carried  out to evaluate  the  antimicrobial  activity  of  the  selected Int. J. Mol. Sci. 2011, 12                       
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medicinal plants on clinical  isolates of H. pylori as part of an ongoing effort to identify potential 
sources of cheap starting materials for the synthesis of new drugs against this carcinogenic organism. 
2. Results and Discussion 
2.1. Extract Yield 
The total amount of crude extract obtained with the different solvents shows that methanol was 
quantitatively the best solvent for extraction in all the plants while ethyl acetate had the lowest yields 
in  four  of  the  five  plants  studied  (Table  1).  The  efficiency  of  methanol  in  the  extraction  of 
phytochemicals has been reported in other studies [13,21,22]. Our results seem to be consistent with 
others confirming methanol as a good solvent for extraction of bioactive compounds from plants as it 
gave the highest yield in all five plants studied. However, the extract yield may not always relate 
proportionally with its activity as revealed by the activity of the methanol extract herein (Figure 1). 
Nevertheless, the activity demonstrated by the methanol extracts gives an indication of their potential 
as useful bioactive substances. 
2.2. Antimicrobial Activity of Extracts 
All  the  plant  crude  extracts  tested  demonstrated  anti-H.  pylori  activity  with  zone  diameters  of 
inhibition between 0 and 38 mm. The highest mean zone diameter of 17.4 ± 5.0 mm was recorded for 
the acetone extract of C. molle (Table 2) which also gave the highest percentage susceptibility  of 
87.1%, followed by acetone and aqueous extracts of S. birrea with 71% each (Figure 1). Strychnos 
species and A. amatymbica gave percentage susceptibilities of less than 50%.  
Table 1. Crude extract yield. 
Percentage of plant crude extract obtained with different solvents 
Plant  Family  EA  A  E  M  W 
Combretum molle R. Br. Ex G. Don  Combretaceae  0.4  1.5  1.1  1.7  1.0 
Sclerocarya birrea A. Rich (Hochst)  Anacardiaceae  0.9  3.3  4.2  5.2  1.9 
Garcinia kola Heckel  Guttiferae  0.5  1.5  1.5  3.2  1.8 
Strychnos species Gilg.  Loganiaceae  0.4  0.6  0.7  4.7  2.3 
Alepidea amatymbica Eckl. and Zeyh  Apiaceae  4.6  1.9  1.2  5.6  2.9 
EA, Ethyl acetate; A, Acetone; E, Ethanol; M, Methanol; W, Water. Int. J. Mol. Sci. 2011, 12                       
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Figure  1.  Activity of plant crude extracts on H. pylori by agar well diffusion  method. 
Percentage susceptibilities are representative  of the  number of strains whose zone  of inhibition 
diameter is ≥14 mm. 
 
Table 2. Screening of plant crude extracts for anti-H. pylori activity. 
Plant  Solvent extract 
Mean zone diameter  
± SD (mm) 
Inhibition diameter  
range (mm) 
C. molle 
Ethyl acetate  10.7 ± 4.7  0–21 
Acetone  17.4 ± 5.0  10–38 
Ethanol  12.9 ± 4.7  7–35 
Methanol  13.1 ± 5.3  7–32 
Water  2.7 ± 5.5  0–20 
Positive control  13.5 ± 8.7  0–32 
S. birrea 
Ethyl acetate  13.2 ± 2.8  8–20 
Acetone  14.7 ± 2.5  11–21 
Ethanol  3.3 ± 5.0  0–16 
Methanol  3.0 ± 4.4  0–11 
Water  15.0 ± 2.7  10–20 
Positive control  16.6 ± 7.4  0–32 
G. kola 
Ethyl acetate  5.1 ± 4.6  0–13 
Acetone  8.8 ± 5.2  0–25 
Ethanol  9.2 ± 7.2  0–19 
Methanol  7.1 ± 5.8  0–20 
Water  1.0 ± 2.6  0–8 
Positive control  16.1 ± 8.3  0–32 Int. J. Mol. Sci. 2011, 12                       
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Table 2. Cont. 
Plant  Solvent extract 
Mean zone diameter  
± SD (mm) 
Inhibition diameter  
range (mm) 
Strychnos sp. 
Ethyl acetate  10.1 ± 6.4  0–26 
Acetone  8.8 ± 6.8  0–26 
Ethanol  4.9 ± 6.2  0–18 
Methanol  5.5 ± 5.9  0–15 
Water  11.9 ± 5.6  0–23 
Positive control  15.5 ± 7.3  0–32 
A. amatymbica 
Ethyl acetate  8.5 ± 4.8  0–17 
Acetone  7.0 ± 6.5  0–20 
Ethanol  6.7 ± 6.7  0–20 
Methanol  6.1 ± 6.4  0–15 
Water  8.0 ± 8.2  0–25 
Positive control  14.4 ± 7.7  0–30 
Data are mean ± SD of 31 determinations for each plant crude extract or control antibiotic. 
MIC values of the plant extracts ranged from 0.06 to 5.0 mg/mL and those of amoxicillin and 
metronidazole ranged from 0.001 to 0.63 mg/mL and 0.004 to 5.0 mg/mL respectively (Table 3). Of 
all the extracts analyzed, the acetone extracts of S. birrea and C. molle exhibited interesting activities 
with MIC values ranging from 0.06 to 2.50 mg/mL and 0.08 to 2.50 mg/mL respectively with no 
significant  differences  between  their  activity  and  that  of  amoxicillin  (P  >  0.05);  as  opposed  to 
metronidazole (P < 0.05). However, the activity of the ethanol extract of G. kola was significantly 
different from amoxicillin (P < 0.05) as opposed to metronidazole (P > 0.05). 
The  antimicrobial  activity  of  the  acetone  extracts  of  C.  molle  and  S.  birrea  (Figure  1)  may  
imply  that  acetone  could  be  a  better  solvent  for the  extraction  of  anti-H.  pylori  compounds  from  
both  plants.  Eloff  [23]  in  a  comparison  of  acetone,  ethanol,  methanol,  methylenedichloride, 
methanol/chloroform/water and water observed acetone to be the best in terms of the diversity  of 
compounds extracted. Such diverse compounds may act in synergy and produce a greater antimicrobial 
effect on H. pylori, thus resulting in high susceptibility patterns and low MIC values observed (Table 3).  
The acetone extracts of C. molle and S. birrea seem to possess significant inhibitory activity against 
H. pylori when compared with metronidazole and amoxicillin. Crude extracts of other plants have been 
shown  to  have  comparable  activity  with  amoxicillin  and  better  activity  when  compared  with 
metronidazole against H. pylori in other studies [1,24]. This is quite remarkable considering that the 
antibiotics are in the purified and concentrated form whereas the extracts are crude and may harbor 
both  pharmacologically  and  non-pharmacologically  active  compounds  with  the  chance  of  some 
compounds having a masking effect over others. This  is an  indication that the acetone extracts of  
C. molle and S. birrea may contain therapeutically useful compounds against H. pylori infections. Int. J. Mol. Sci. 2011, 12                       
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Table 3. Minimum inhibitory concentrations (MIC50) of plant crude extracts and control 
antibiotics (mg/mL). 
Crude extracts/Antibiotics 
H. pylori strains  AC  AS1  AS2  EG  AMPC  MNZ 
PE2A  0.312  0.06  0.47  5.0  0.32  1.25 
PE5A  0.625  0.12  0.63  1.25  0.63  1.25 
PE9C  1.25  0.08  0.63  1.25  0.01  2.5 
PE11A  0.156  1.25  0.16  5.0  0.04  5.0 
PE11C  0.156  0.08  0.63  1.25  0.04  1.25 
PE14C  0.156  0.06  0.47  1.25  0.31  1.25 
PE26A  0.312  0.63  1.25  1.25  0.63  1.25 
PE70A  0.625  0.06  0.94  1.25  0.32  2.5 
PE76A  1.25  2.5  2.5  5.0  0.31  5.0 
PE84C  0.625  1.25  –  1.25  0.63  1.25 
PE93A  0.08  0.06  0.63  1.25  0.32  2.5 
PE93C  1.25  0.16  0.47  1.25  0.63  1.25 
PE102C  0.156  0.31  2.5  1.25  0.63  1.25 
PE115A  0.312  0.63  1.25  1.25  0.31  5.0 
PE155A  2.5  0.08  0.94  1.25  0.16  2.5 
PE219C  1.25  0.94  –  1.25  0.31  1.25 
PE252C  0.312  1.25  2.5  1.25  0.63  2.5 
PE258C  0.312  0.94  2.5  1.25  0.08  3.75 
PE369A  0.312  0.63  0.31  1.25  0.31  0.08 
PE369C  0.625  0.31  0.31  1.25  0.31  2.5 
PE397C  0.312  0.08  1.5  5.0  0.01  5.0 
PE402A  1.25  0.06  0.49  5.0  0.32  2.5 
PE411A  0.625  0.08  0.63  1.25  0.08  2.5 
PE411C  1.25  0.63  0.63  1.25  0.31  1.25 
PE430A  0.312  1.25  –  1.25  0.31  1.25 
PE430C  0.625  0.31  0.47  1.25  0.31  1.25 
PE435A  0.625  0.63  1.25  0.63  0.31  1.25 
PE436A  1.25  0.08  0.63  0.63  0.31  0.04 
PE436C  0.312  1.25  2.5  1.25  –  1.25 
PE466C  0.312  0.36  2.5  1.25  0.31  1.25 
NCTC 11638  0.312  0.63  2.5  2.5  0.001  0.004 
Mean ± SD  0.63 ± 0.53  0.54 ± 0.56  1.0 ± 0.85  1.85 ± 1.42  0.30 ± 0.20  2.1 ± 1.42 
AC,  Acetone  extract  of C.  molle;  AS1,  Acetone  extract  of S.  birrea;  AS2,  Aqueous  extract  of  
S. birrea; EG, Ethanol extract of G. kola; AMPC, Amoxicillin; MNZ, Metronidazole; –, Value not 
within susceptible range; SD, Standard deviation. The results shown are representative of duplicate 
determinations for each strain and 31 determinations for each extract or control antibiotic. Strains 
bearing letter “A” were isolated from the antrum while those bearing letter “C” were isolated from 
the corpus. The resistant breakpoint for amoxicillin and  metronidazole  was >0.002 mg/mL and 
>0.008  mg/mL  respectively.  Except  for  the  standard  control  strain,  all  the  strains  tested  were 
resistant to amoxicillin and metronidazole giving a percentage resistance of 96.7%.  
 Int. J. Mol. Sci. 2011, 12                       
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The results of this study  indicate a 96.7% resistance of the strains tested to metronidazole and 
amoxicillin (Table 3). This high resistance is probably due to the fact that all the clinical strains used 
were isolated from patients with a history of recurrent peptic ulcer infection in the hospital, where 
there is a high chance of finding resistant bacteria. H. pylori-resistance to metronidazole has been an 
existing problem [1,25], especially in the developing world and can be attributed to wide usage of this 
drug  in  the  treatment  of  other  infections,  especially  parasitic  and  gynaecological  infections  [26].  
Our results are consistent with other studies indicating that amoxicillin resistance, previously reported 
to be rare, is rising at an alarming rate, especially in third world countries where drug prescription 
practices  are  probably  not  adhered  to  [1,27].  The  consequence  will  be  an  increase  in  eradication 
failure, encouraging clinicians to resort to second and third line therapies, some of which may require 
drug combinations that are not readily available in South Africa. Therefore, the present results indicate 
the need to test the antimicrobial susceptibility of H. pylori in the country to guide empiric treatment.  
A careful look at Table 3 shows that patients may be co-infected with mixed antibiotic-resistant/ 
susceptible  strains  at  the  same  time,  in  the  same  or  different  sites  of  the  stomach  which  is  in 
concordance with the findings of many other researchers [28–30]. It therefore becomes imperative for 
gastric biopsies to be collected from different parts of the stomach and to analyze the susceptibility 
patterns of bacteria isolated from different sites (antrum/corpus) of the same patient. 
2.3. Bactericidal Activity 
There seem to be a linear relationship exhibited by the bactericidal activity of the extracts with time 
and concentration. For example, at 1.2 mg/mL (2× MIC) a killing rate of 54.4% of H. pylori was 
recorded for the acetone extract of S. birrea after 12 h and complete eradication of the organisms after 
18 h. When this concentration was doubled (2.4 mg/mL) (4× MIC), the killing rate was more than 90% 
after 12 h with complete eradication of the organisms after 18 h (Figure 2a).The relationship was 
almost the same for the acetone extract of C. molle with a 35.0% and 55.0% killing within 18 h at  
1.2  mg/mL  (2×  MIC)  and  2.4  mg/mL  (4×  MIC)  respectively;  and  complete  elimination  of  the 
organisms within 24 h at the same concentrations (Figure 2b). These findings seem to corroborate the 
observations  of  Akinpelu  et  al.  [31]  who  reported  the  rate  of  killing  of  Escherichia  coli  and  
Bacillus subtilis by the aqueous fractions of Afzelia africana to be dependent on time and extract 
concentration. However H. pylori was not among the organisms tested and unlike in Akinpelu’s study 
where fractions were used, our extracts are still crude with better activity expected upon fractionation 
and purification from pharmacologically inactive substances that may interfere with the assay. 
A relatively lower bactericidal activity was however noticed with the aqueous extract of S. birrea. 
Even though there was a consistent increase in the percentage of H. pylori killed with time at MIC,  
2× MIC and 4× MIC, this was not maintained to the end of the assay (Figure 2c). The peak bactericidal 
activity exhibited by the extract at the 36th hour coincides with the exponential growth phase of the 
organisms, a time during which they are most sensitive to antimicrobial agents. It is likely that some of 
the organisms that survived this period were already becoming resistant to the extract after 36 h. From 
all indications, the aqueous extract of S. birrea was only weakly bactericidal. Int. J. Mol. Sci. 2011, 12                       
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Figure 2. (a) Rate of killing of H. pylori by the acetone extract of S. birrea; (b) Rate of 
killing of H. pylori by the acetone extract of C. molle; (c) Rate of killing of H. pylori by the 
aqueous  extract of  S.  birrea.  Percentage  of  H. pylori  killed  represents  mean  values  of 
triplicate determinations for the strains PE2A, PE14C and PE93A. Error bars represent the 
standard deviation (SD). Very small error bars have been obscured by data symbols. Neg. 
Control, extract-free cells.  
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It is worth mentioning that the literature is rich with information on the very limited activity or 
complete non responsiveness of microorganisms to plant aqueous extracts [19,32,33]. Our study lays 
credence to this as aqueous extracts of 4 of the 5 plants studied recorded percentage susceptibilities of 
less than 50%. However, these results also provide evidence that water could still be a good solvent  
in the extraction of anti-H. pylori compounds  from S. birrea as it gave an activity of 71% in the 
screening (Figure 1). This is particularly important in the study area and other rural settings in Africa 
where organic solvents reported to be better solvents for extraction [13,34] may not be within the reach 
of the traditional healers, as most of them make use of aqueous extracts in their practice. Equally 
important is the fact that the use of water is environmentally safer than most organic solvents. 
Crude ethanol extracts of G. kola seeds exhibited a better activity when compared to metronidazole 
(P  >  0.05),  a  pure  compound.  This  is  not  surprising  given  the  high  H.  pylori  resistance  to 
metronidazole  in  South  Africa  [25].  Equally  important  is  the  fact that the  seeds  of  this  plant  are 
reported  to  be  rich  in  flavonoids  and  tannins,  substances  with  great  antimicrobial  potentials  and  
health-promoting abilities [35,36]. Synergistic  interactions between some of these compounds  may 
produce greater antimicrobial activity against H. pylori. The antimicrobial activity demonstrated by the 
ethanolic extract of G. kola is an indication of its potential as a possible source of new compounds 
against H. pylori infections.  
The  antimicrobial  activity  demonstrated  by  crude  extracts  of  the  lone  Strychnos  species  and  
A. amatymbica was relatively low (Figure 1). It is likely that the amount of active ingredients in these 
plant extracts may not occur in quantities large enough to produce significant activity. Such extracts 
upon  fractionation,  purification  and  concentration  of  the  active  ingredients  may  still  lead  to  the 
isolation of therapeutically useful compounds against H. pylori or other infectious organisms.  
3. Experimental 
3.1. Bacterial Strains 
A total of thirty strains of H. pylori were isolated from gastric biopsies of patients with recurrent 
peptic ulcer infection undergoing endoscopy at the Livingstone hospital, Port Elizabeth and confirmed 
following our previously reported scheme [1]. A reference strain of H. pylori (NCTC 11638) was also 
included in the study. Ethical clearance was obtained from the Eastern Cape Department of Health and 
the Govan Mbeki Research and Development Centre, University of Fort Hare. Specimens were only 
collected from patients who had given consent and had not received antibiotics or PPIs for at least  
a week. Pure cultures were suspended in eppendorf tubes containing 1 mL of Brain Heart Infusion 
(BHI) broth (Oxoid LTD, Basingstoke, Hampshire, England) and 20% glycerol and stored at −80 °C 
(Ilshin
®, Model DF 9007, Sanyo, Osaka, Japan) for future experiments. 
3.2. Preparation of Plant Material 
The  plants  were  selected  based  on  ethno  botanical  information.  The  stem  barks  of  
Combretum  molle  R.  Br.  Ex  G.  Don  (Combretaceae)  and  Sclerocarya  birrea  A.  Rich  Hochst 
(Anacardiaceae) were harvested in the vicinity of the University of Venda, Limpopo Province. The 
stem  bark  of  a  single  Strychnos  species  Gilg.  (Loganiaceae)  and  the  roots/rhizomes  of  Int. J. Mol. Sci. 2011, 12                       
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Alepidea Amatymbica Eckl. and Zeyh (Apiaceae) were purchased from the traditional medicine market 
in  King  William’s  town  and  amayeza  yesiXhosa  (Xhosa  medicine)  stores  in  Alice.  The  seeds  of  
G. kola Heckel (Guttiferae) were purchased from a local market in Cameroon. C. molle was identified 
by botanists at the University of Venda where vouchers have been deposited. The rest of the plants 
were identified by botanists in the phytomedicine research unit at the University of Fort Hare and 
vouchers deposited in the Giffen herbarium. The plant materials were washed, separately chopped into 
small pieces and dried in a hot air oven (Schwabach, Germany) at 40 °C for 48 h. The plant material 
was powdered (ATO mix, Torrington, CT, USA) and stored in air tight containers in a dark cupboard 
for future use. 
3.3. Preparation of Plant Extract 
Exactly  300  g  of  dried  powdered  plant  material  was  macerated  separately  in  600  mL  of 
concentrated ethyl acetate, acetone, ethanol and methanol (Merck, Wadeville, Gauteng, South Africa) 
in  large glass bottles (SIMAX, Sazava, Czech  Republic). Aqueous extracts were also prepared by 
soaking same amount of plant material in tap water. The bottles were labeled and put in an orbital 
shaker (New Brunswick Scientific, Edison, NJ, USA) for 48 h. The plant extracts were centrifuged at 
1006.2 g for 5 min, and filtered using a fritted filter funnel of pore size 60 Å. The procedure was 
repeated twice and the three extracts combined and evaporated to dryness under vacuum in a rotary 
evaporator (BUCHI rota vapour, Flavil/Schweiz, Switzerland) set at temperatures depending on the 
solvent  in  use.  The  filtrate  obtained  from  aqueous  extracts  was  lyophilized  [24]. The  dried  crude 
extracts  were  collected  in  clean  universal  bottles  and  left  open  in  a  bio-safety  class  11  cabinet  
(Vivid Air, Durban, South Africa) for complete evaporation of residual solvents. A 2-g sample of each 
extract was used for the preliminary bioassay, and where possible, another 2 g was kept in the extract 
bank. Stock solutions were prepared by dissolving the extracts in dimethyl sulphoxide (DMSO) or 
acetone; 10% and 80% respectively (neither DMSO nor acetone were inhibitory to the H. pylori strains 
at the tested concentrations). 
3.4. Screening of Crude Extracts for Anti-H. pylori Activity 
This was achieved by the agar well diffusion method as previously reported [37]. Briefly, H. pylori 
inocula prepared at McFarland’s turbidity standard 2 was plated onto BHI agar supplemented with  
5% horse blood and Skirrow’s supplement (Oxoid, England). The inocula was evenly spread on the 
plate and allowed to dry for 15 min. Wells (6 mm in diameter) were punched into the agar using a 
sterile stainless steel borer and filled with 65 µL of the extract at 100 mg/mL. Sixty five micro liters of 
0.05 µg/mL clarithromycin and 10% DMSO were included in all experiments as positive and negative 
controls respectively. The plates were incubated under microaerophilic conditions (Anaerocult, Oxoid, 
UK) at 37 °C for 72 h after which the diameters of zones of inhibition were measured in millimeters. 
The experiment was repeated once and  mean zones were recorded. A Helicobacter pylori control 
strain, NCTC 11638-inoculated plate was included in all the experiments. Int. J. Mol. Sci. 2011, 12                       
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3.5. Determination of 50% Minimum Inhibitory Concentration (MIC50) 
Active extracts that had given a percentage susceptibility of ≥50% by agar well diffusion were 
selected for further determination of MICs by the  micro broth dilution  method [38], performed in  
96-well plates. The test extracts were prepared at a concentration of 5.0 mg/mL and filtered through a 
2.0 µm filter (Acrodisc Pall, MI, USA). Two-fold
 dilutions of each extract were made in the test wells 
in  BHI  broth  supplemented  with  5%  horse  serum  and  Skirrow’s  supplement  (Oxoid,  England).  
The final extract concentrations ranged from 0.002 to 5.0 mg/mL. Twenty micro liters
 of an 18-h old 
broth culture of H. pylori (McFarland’s turbidity standard 2) suspension was added to 180 µL of  
extract-containing
  culture  medium.  Control  wells  were  prepared  with  culture  medium
  only  and 
bacterial suspension and broth only respectively. Metronidazole and amoxicillin were run alongside 
each batch of extracts at 0.002–5.0 mg/mL and 0.0005–5.0 mg/mL concentration ranges respectively. 
An automatic ELISA micro plate reader (Tokyo, Japan) adjusted to 620 nm was used to measure the 
absorbance of the plates before and after 72-h incubation at 37 °C under microaerophilic conditions. 
The absorbencies were compared to detect an increase or decrease in bacterial growth and the values 
plotted against concentration. The lowest concentration of the test extract resulting in inhibition of 
50% of bacterial growth was recorded as the MIC. 
3.6. Determination of Rate of Killing 
The most active plant crude extracts with mean MIC values ≤1.0 mg/mL were considered for the 
rate of kill experiments. The rate and extend of killing of H. pylori by the acetone extracts of C. molle 
and  S.  birrea  as  well  as  the  aqueous  extract  of  the  latter  were  determined  as  described  by  
Akinpelu et al. [31] with slight modifications. The turbidity of an 18-h old broth culture of H. pylori 
was  standardized  to  10
8  CFU/mL.  One  mill  of  this  suspension  was  added to  9  mL  of  BHI  broth 
supplemented with 5% horse serum and Skirrow’s reagents and containing the extract at 1/2× MIC, 
MIC, 2× MIC and 4× MIC in McCartney bottles (Oxoid, England). A negative control bottle was 
prepared with bacterial suspension and broth only. 
A 0.1-mL sample was plated from these bottles before incubation at 37 °C under microaerophilic 
conditions. Exactly 0.5 mL volume of each suspension was withdrawn at 6-h interval for 72 h and 
transferred to 4.5 mL of BHI broth recovery medium containing 3% “Tween 80” to neutralize the 
effects of the antimicrobial extract carry-overs from the test organisms. The suspension was 10-fold 
serially diluted in sterile saline (0.9% w/v sodium chloride) and plated in triplicates. The plates were 
incubated at 37 °C for 72 h under microaerophilic conditions and viable counts determined. Counts 
obtained  from extract containing culture bottles were compared with those of the negative control 
bottle and the percentage of bacteria killed was determined.  
3.7. Statistical Analysis 
The statistical packages used for analysis were Excel (Microsoft, Redmond, WA, USA) and SPSS 
version 17.0 (2009, SPSS, Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA) was used 
to  compare  the  mean  difference  in  inhibitory  activities  of  extracts  and  antibiotics,  followed  by 
Turkey’s post-hoc test. Differences were considered significant at P < 0.05.  Int. J. Mol. Sci. 2011, 12                       
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4. Conclusion 
All the plants studied herein demonstrated considerable anti-H. pylori activity. This study may thus 
serve as preliminary scientific validation of their folkloric uses in the treatment of infections due to  
H. pylori in South Africa. C. molle, S. birrea and G. kola may contain compounds  mostly  in the 
acetone, acetone/aqueous and ethanol crude extracts respectively that could be used as lead molecules 
for the synthesis of novel drugs against this carcinogenic organism. Isolation and characterization of 
the plant active components is our next line study.  
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